Biotechnology - Licensing, Vaccines

Filter

Current filters:

LicensingVaccines

Popular Filters

Dutch biotech Mucosis partners with Chinese firm

Dutch biotech Mucosis partners with Chinese firm

15-04-2014

Dutch biotech company Mucosis has entered into a long-term collaboration and license agreement with China-based…

BiotechnologyChangchunChief executiveChinaDiseaseHuman respiratory syncytial virusLicensingMimopath technologyNetherlandsVaccines

Valneva deal with Emergent BioSolutions for development of vaccines in the EB66 cell line

11-03-2014

European biotechnology company Valneva has signed a new research license agreement and transferred an…

BiotechnologyEB66 cell lineEmergent BioSolutionsLicensingVaccinesValneva

Valneva initiates fourth antibody discovery program for Sanofi Pasteur

25-02-2014

European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Valneva licenses EB66 to IAVI for preventive HIV vaccine

02-10-2013

Biotech firm Valneva says that it has licensed the use of its EB66 cell line to the International AIDS…

Anti-viralsBiotechnologyLicensingVaccinesValneva

Agenus and VaxLogic licensing accord on QS-21 Stimulon adjuvant

Agenus and VaxLogic licensing accord on QS-21 Stimulon adjuvant

27-09-2013

US biotech firm Agenus has entered into a non-exclusive license agreement with VaxLogic, a subsidiary…

AgenusBiotechnologyLicensingNorth AmericaPharmLogicVaccinesVaxLogic

Immune Design and Medicago link up to develop flu vaccines

01-07-2013

Privately-held US biotech firm Immune Design and Medicago (TSX: MDG), a Canadian biopharmaceutical company…

Anti-viralsBiotechnologyImmune DesignLicensingMedicagoVaccines

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen

07-01-2013

Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer…

BiotechnologyDekavilGlycoVaxynInflammatory diseasesJanssenJohnson & JohnsonLicensingPfizerPharmaceuticalPhilogenVaccines

Emergent BioSolutions gets exclusive US commercial rights to pandemic flu vaccine candidate

31-12-2012

US vaccine maker Emergent BioSolutions (NYSE: EBS) has signed a license agreement with fellow USA-based…

BiotechnologyEmergent BioSolutionsLicensingNorth AmericaVaccinesVaxInnate Corp

Galena Biopharma leaps on deal with Teva for NeuVax in Israel

05-12-2012

Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

Sanofi inks up to $900 million allergy pact with Selecta Biosciences

28-11-2012

US clinical-stage biopharma company Selecta Biosciences revealed this morning that it has entered into…

BiotechnologyImmunologicalsLicensingPharmaceuticalResearchSanofiSelecta BiosciencesVaccines

Silencing investor concerns? Alnylam achieves RNAi milestone

02-08-2012

US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) has received a $3.2 million milestone…

Alnylam PharmaceuticalsAnti-viralsBiotechnologyFinancialGlaxoSmithKlineLicensingProductionVaccines

Vivalis signs another EB66 out-licensing deal for MAb production

14-03-2012

French biotech firm Vivalis (NYSE Euronext: VLS) has signed a joint collaboration and commercial license…

BiotechnologyEB66LicensingVaccinesVivalis

Agenus expands deal with GlaxoSmithKline; Nuron in-licenses vaccines

06-03-2012

US biotech firm Agenus (Nasdaq: AGEN) says it has amended the QS-21 license and manufacturing agreement…

AgenusAkshaya BioBiotechnologyGlaxoSmithKlineLicensingNuron BiotechPharmaceuticalVaccines

Sanofi Pasteur and CureVac collaborate on a $33.1 million project on vaccines for infectious diseases

16-11-2011

Germany’s CureVac says it has signed several agreements with Sanofi Pasteur, the vaccines division…

Antibiotics and Infectious diseasesBiotechnologyCureVacLicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Gilead collaborates with GlobeImmune to develop vaccine for chronic hepatitis B infection

25-10-2011

Gilead Sciences (Nasdaq: GILD) has entered into an exclusive worldwide license and collaboration agreement…

Anti-viralsBiotechnologyGilead SciencesGlobeImmuneLicensingResearchVaccines

Back to top